Review





Similar Products

94
Multi Sciences (Lianke) Biotech Co Ltd anti rat il 17
Anti Rat Il 17, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti rat il 17/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 94 stars, based on 1 article reviews
anti rat il 17 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Bioss il 17 a
Il 17 A, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 17 a/product/Bioss
Average 90 stars, based on 1 article reviews
il 17 a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

94
Proteintech mouse anti il 17 antibody
Mouse Anti Il 17 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti il 17 antibody/product/Proteintech
Average 94 stars, based on 1 article reviews
mouse anti il 17 antibody - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Proteintech il17a
Il17a, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il17a/product/Proteintech
Average 94 stars, based on 1 article reviews
il17a - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
Bioss il 17a
Il 17a, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 17a/product/Bioss
Average 93 stars, based on 1 article reviews
il 17a - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

94
Proteintech il 17a
HGFAC, KRT7 and Megasphaera micronuciformis are implicated in the onset and progression of CDPS. A . Experimental design for DSS and imiquimod mouse model. B . Representative images of the colon and skin of DSS and imiquimod treated mice in each group. C . Line chart shows body weight changes of each group in DSS and imiquimod mouse model. D . Bar chart shows colon length of each group in DSS and imiquimod mouse model; Student's t -test, ∗p < 0.05; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. E . Bar chart shows spleen/body ratio of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. F . Bar chart shows skin thickness of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. G . Bar chart shows PASI score of each group in DSS and imiquimod mouse model; Student's t -test, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. H . H&E staining of colon of each group in DSS and imiquimod mouse model; inflammatory cell infiltration is indicated by red arrows; scale bars: 50 μm. I . Bar chart shows histological scores of colon of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01; WT (n = 6), KRT7 KO (n = 6); WT (n = 6), HGFAC KO (n = 6); PBS (n = 6), M. micronuciformis (n = 6); error bars represent the mean ± SD. J . Bar chart shows serum TG, LDL and HDL levels of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; WT (n = 6), KRT7 KO (n = 6); WT (n = 6), HGFAC KO (n = 6); PBS (n = 6), M. micronuciformis (n = 6); error bars represent the mean ± SD. K . Oil red staining of intestinal mucosa and skin of each group in DSS and imiquimod mouse model; scale bars: 100 μm. L . The colon and skin protein expression of TNF-α <t>and</t> <t>IL-17</t> of each group in DSS and imiquimod mouse model was determined by western blotting.
Il 17a, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 17a/product/Proteintech
Average 94 stars, based on 1 article reviews
il 17a - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


HGFAC, KRT7 and Megasphaera micronuciformis are implicated in the onset and progression of CDPS. A . Experimental design for DSS and imiquimod mouse model. B . Representative images of the colon and skin of DSS and imiquimod treated mice in each group. C . Line chart shows body weight changes of each group in DSS and imiquimod mouse model. D . Bar chart shows colon length of each group in DSS and imiquimod mouse model; Student's t -test, ∗p < 0.05; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. E . Bar chart shows spleen/body ratio of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. F . Bar chart shows skin thickness of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. G . Bar chart shows PASI score of each group in DSS and imiquimod mouse model; Student's t -test, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. H . H&E staining of colon of each group in DSS and imiquimod mouse model; inflammatory cell infiltration is indicated by red arrows; scale bars: 50 μm. I . Bar chart shows histological scores of colon of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01; WT (n = 6), KRT7 KO (n = 6); WT (n = 6), HGFAC KO (n = 6); PBS (n = 6), M. micronuciformis (n = 6); error bars represent the mean ± SD. J . Bar chart shows serum TG, LDL and HDL levels of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; WT (n = 6), KRT7 KO (n = 6); WT (n = 6), HGFAC KO (n = 6); PBS (n = 6), M. micronuciformis (n = 6); error bars represent the mean ± SD. K . Oil red staining of intestinal mucosa and skin of each group in DSS and imiquimod mouse model; scale bars: 100 μm. L . The colon and skin protein expression of TNF-α and IL-17 of each group in DSS and imiquimod mouse model was determined by western blotting.

Journal: eBioMedicine

Article Title: Significance of integrated clinical and proteomic characteristics analysis for pathogenesis and management of Crohn's disease with concomitant psoriasis

doi: 10.1016/j.ebiom.2025.105981

Figure Lengend Snippet: HGFAC, KRT7 and Megasphaera micronuciformis are implicated in the onset and progression of CDPS. A . Experimental design for DSS and imiquimod mouse model. B . Representative images of the colon and skin of DSS and imiquimod treated mice in each group. C . Line chart shows body weight changes of each group in DSS and imiquimod mouse model. D . Bar chart shows colon length of each group in DSS and imiquimod mouse model; Student's t -test, ∗p < 0.05; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. E . Bar chart shows spleen/body ratio of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. F . Bar chart shows skin thickness of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. G . Bar chart shows PASI score of each group in DSS and imiquimod mouse model; Student's t -test, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; WT (n = 8), KRT7 KO (n = 8); WT (n = 8), HGFAC KO (n = 8); PBS (n = 9), M. micronuciformis (n = 9); error bars represent the mean ± SD. H . H&E staining of colon of each group in DSS and imiquimod mouse model; inflammatory cell infiltration is indicated by red arrows; scale bars: 50 μm. I . Bar chart shows histological scores of colon of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01; WT (n = 6), KRT7 KO (n = 6); WT (n = 6), HGFAC KO (n = 6); PBS (n = 6), M. micronuciformis (n = 6); error bars represent the mean ± SD. J . Bar chart shows serum TG, LDL and HDL levels of each group in DSS and imiquimod mouse model; Student's t -test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; WT (n = 6), KRT7 KO (n = 6); WT (n = 6), HGFAC KO (n = 6); PBS (n = 6), M. micronuciformis (n = 6); error bars represent the mean ± SD. K . Oil red staining of intestinal mucosa and skin of each group in DSS and imiquimod mouse model; scale bars: 100 μm. L . The colon and skin protein expression of TNF-α and IL-17 of each group in DSS and imiquimod mouse model was determined by western blotting.

Article Snippet: The primary antibodies used were KRT7 (RRID: AB_2881849 , 66483-1-Ig, Proteintech), TNF-α (RRID: AB_2833255 , 60291-1-Ig, Proteintech), IL-17A (RRID: AB_2881544 , 66148-1-Ig, Proteintech), and β-Actin (RRID: AB_2687938 , 66009-1-Ig, Proteintech).

Techniques: Staining, Expressing, Western Blot